Editsprings@163.com (周一至周日,9:00-23:00) | (周一至周日,9:00-23:00)

SCI论文全攻略之审稿回复实例,审稿,全,EditSprings,艾德思

网络 | 2018/11/21 15:52:07  | 159 次浏览

   sci扩展版(以下简称sciE)和sci核心版(以下简称sci)收录期刊还是有区别的,sci期刊文章部被sci收录,sciE期刊文章只是部分被sci收录,这就是有的sciE期刊一年有几百篇文章,却只有几十篇甚至十几篇文章被sci收录的原因.具体到sciE期刊上的一篇文章是否被sci收录,还是要看美国ISI发布的报告,现在科技部信息研究所也公布这一报告,很多图书馆的sci检索公司也可以查.

   不过在国内,很多单位都把sci期刊文章和sciE期刊文章一视同仁,只要发表在sci期刊或sciE期刊上,该文章都当作sci收录,这是管理者的无能抑或无为就不得而知了.但就我们单位而言(国内TOP10高校),这两者还是区别对待的,文章是否sci收录还是看CISI的报告或sci检索公司的证

附2:[精华]怎样回复sci投稿审稿人建议(1)

1.所有问题必须逐条回答.

2.尽量满足建议中需要补充的实验.

3.满足不了的也不要回避,说明不能做的合理理由.

4.审稿人推荐的文献一定要引用,并讨论透彻.

以下是本人对审稿人建议的回复一例,仅供参考.

续两点经验:

1,最重要的是逐条回答,即使您答不了,也要老实交代;不要太狡猾,以至于耽误事;

2,绝大部分实验是不要真追加的,除非您受到启发,而想该投另外高档杂志----因为您既然已经写成论文,从逻辑上肯定是一个完整的 "story' 了.

以上指国际杂志修稿.国内杂志太多,以至于稿源吃紧,基本没有退稿,所以您怎么修都是接受.

我的论文水平都不高,主要是没有明显的创新性,也很苦恼.但是除了开始几篇投在国内杂志外,其他都在国际杂志(也都是sci)发表.以我了解的情况,我单位其他同志给国内杂志投稿,退稿的极少,只有一次被<某某科学进展>拒绝.究其原因,除了我上面说的,另外可能是我单位写稿子还是比较严肃,导师把关也比较严的缘故.

自我感觉总结(不一定对):

1)国内杂志审稿极慢(少数除外),但现在也有加快趋势;

2)国内杂志编辑人员认真负责的人不多,稿子寄去后,少则几个月,多则一年多没有任何消息;

3)国内杂志要求修改的稿子,如果您自己不修,他最后也给您发;

4)国外杂志要求补充实验的,我均以解释而过关,原因见少帖).还因为:很少杂志编辑把您的修改稿再寄给当初审稿人的,除非审稿人特别请求.编辑不一定懂您的东西,他只是看到您认真修改,回答疑问了,也就接受了(当然高档杂志可能不是这样,我的经验只限定一般杂志(影响因子1-5).

欢迎大家批评指正.

我常用的回复格式,呵呵.

Dear reviewer:

I am very grateful to your comments for the manuscript. According with your advice, we amended the relevant part in manuscript. Some of your questions were answered below.

1)

2)

....

引用审稿人推荐的文献的确是很重要的,要想办法和自己的论文有机地结合起来.至于实验大部分都可以不用补做,关键是您要让审稿人明白您的论文的重点是什么,这个实验对您要强调的重点内容不是很必要,或者您现在所用的方式已经可以达到目的就行了.最后要注意,审稿人也会犯错误,不仅仅是笔误也有专业知识上的错误,因为编辑找的审稿人未必是您这个领域的专家.只要自己是正确的就要坚持.在回复中委婉地表达一下您的建议,不过要注意商讨语气哦!

我得回复格式是这样的:

Dear Professor xx:

Thank you very much for your letter dated xxx xx xxxx, and the referees' reports. Based on your comment and request, we have made extensive modification on the original manuscript. Here, we attached revised manuscript. in the formats of both PDF and MS word, for your approval. A document answering every question from the referees was also summarized and enclosed. A revised manuscript. with the correction sections red marked was attached as the supplemental material and for easy check/editing purpose. Should you have any questions, please contact us without hesitate.

然后再附上Q/A,基本上嘱条回答,写的越多越好(老师语).结果修改一次就接收了:)

我的回复,请老外帮忙修改了

Dear Editor:

Thank you for your kind letter of "......' on November **, 2005. We revised the manuscript. in accordance with the reviewers' comments, and carefully proof-read the manuscript. to minimize typographical, grammatical, and bibliographical errors.Here below is our description on revision according to the reviewers' comments. Part A (Reviewer 1). The reviewer's comment: ......

The authors' Answer: .....

2. The reviewer's comment: ......

The authors' Answer: .....

...

...

Part B(Reviewer 2)

1. The reviewer's comment: ......

The authors' Answer: .....

2. The reviewer's comment: ......

The authors' Answer: .....

...

...

Many grammatical or typographical errors have been revised.All the lines and pages indicated above are in the revised manuscript.

Thank you and all the reviewers for the kind advice.

Sincerely yours,

***

[精华]怎样回复sci投稿审稿人建议(2)

 一个回复的例子(已接收)

Major comments:

1. The authors need to strengthen their results by including MMP secretion, and tran-matrigel migration by a positive control progenitor cell population i.e. enriched human CD34 cells obtained from mobilized PBL, since this is a more clinically relevant source of CD34 cells which has also been shown to secrete both MMP-9 and MMP-2 (ref. 11). CD34 enriched cells from steady state peripheral blood which also secrete MMPs are also of interest.

2. In fig1Cplease specify which cell line represents MMP-negative cells. This needs to be clarified, as well as a better explanation of the method of the protocol.

3. The ELISA results are represented as "fold increase" compared to control. Instead, we suggest that standards should be used and results should be presented as absolute concentrations and only then can these results be compared to those of the zymography.

4. When discussing the results, the authors should distinguish clearly between spontaneous migration vs chemotactic migration.Furthermore, the high spontaneous migration obtained with cord blood CD34 cells should be compared to mobilized PBL CD34 enriched cells and discussed.

5. The authors claim that the clonogenic assay was performed to determine the optimum concentration for inhibition of MMP activity by phenanthroline and anti MMP-9 mAb, however they should clarify that this assay can only determine the toxicity of the inhibitors and not their optimal inhibitory concentrations.

Minor comments:

1. There are many spelling and syntax errors, especially in the results and discussion, which need correction.

a. Of special importance, is the percent inhibition of migration,which is described as percent of migration. i.e. pg 7:"Migration of CB CD34 was reduced to 73.3%?" Instead should read "Migration of CB CD34 was reduced by 73.3%?"

b. The degree symbol needs to be added to the numbers in Materials and methods.

2. It would be preferable to combine figure1Aand B, in order to confirm the reliability of fig. 1B by a positive control (HT1080).

Answer to referee 1 comment:

1. Mobilized peripheral blood is a more clinical source of CD34+ cells, so it is necessary to compare the MMP-9 secretion and trans-migration ability of CB CD34+ cells with that of mobilized PB CD34+ cells. However, we couldn't obtain enough mobilized PB to separate PB CD34+ cells and determine the MMP-9 secretion and migration ability, so we couldn't complement the study on PB CD34+ cells in this paper. Results obtained by Janowska-Wieczorek et al found that mobilized CD34+ cells in peripheral blood express MMP-9. Furthermore, Domenech's study showed that MMP-9 secretion is involved in G-CSF induced HPC mobilization. Their conclusions have been added in the discussion. In our present study, our central conclusion from our data is that freshly isolated CD34+ stem/progenitor cells obtained from CB produce MMP-9.

2. MMP-9 negative cell used in fig1Cwas Jurkat cell. In zymographic analysis, MMP-9 was not detected in the medium conditioned by Jurkat cell. To exclude that the contaminating cells may play a role in the observed MMP-9 production, we screened the media conditioned by different proportion of CB mononuclear cells with MMP-9 negative cells by zymography. This result may be confusion. Actually, only by detecting the medium conditioned by 2X105 CB mononuclear cells (MNC)/ml (since the purities of CD34+ cell are more than 90%), it could exclude the MNC role. In the revised manuscript, we only detected MMP-9 activity and antigen level in the medium conditioned by 2X105 CB mononuclear cells (MNC)/ml. There is no MMP-9 secretion be detected in the medium conditioned by 2X105 CB MNC/ml. It excluded the possibility that the MMP-9 activity in CB CD34+ cells conditioned medium is due to the contamination by MNC.

3.In this revised paper, we have detected the MMP-9 antigen levels by using commercial specific ELISA kits (R&D System, sensitivity, ). Recombinant MMP-9 from R&D System was used as a standard. The results are expressed in the absolute concentration. The absolute concentration result has been added in the paper. As shown in Fig2, MMP-9 levels were detectable in both CB CD34+ cell conditioned medium and BM CD34+ cell conditioned medium. However, MMP-9 level was significantly higher in CB CD34+ cell conditioned medium than in BM CD34+ cell conditioned medium (±0.133ng/ml versus 0.195±). Although gelatinolytic activity was not detected in media conditioned by CD34+ cells from BM, sensitivity of ELISA favors the detection of MMP-9 antigen in the BM CD34+.

4. In our study, to establish the direct link between MMP-9 and CB CD34+ cells migration, we only determined the role of MMP-9 inspontaneous migration of CB CD34+ cells, but not in chemotactic migration. Actually, regulation of hematopoietic stem cell migration, homing and anchorage of repopulation cells to the bone marrow involves a complex interplay between adhesion molecules, chemokines, cytokines and proteolytic enzymes. Results obtained by the groups of Voermans reveal that not only the spontaneous migration but also the SDF-1 induced migration of CB CD34+ cells is greatly increased in comparison to CD34+ cells from BM and peripheral blood.

5. CD34+ cells we obtained in each cord blood sample were very limited. It is not enough to screen the inhibitors concentrations to select the optimal inhibitory concentrations. In the blocking experiments, based on the concentrations used by others and the manufacturer's recommendation, we then determined the inhibitors concentrations by excluding the toxicity of the inhibitors in that concentration, which was determined by clonogenic assay.

Minor comments:

1.The spelling and syntax errors have been checked and corrected.

2.Since the results in figure1Aand B were obtained from two separated and parallel experiments, it is not fitness to combine two figures.

这是我的一篇修稿回复,杂志是JBMR-A,影响因子,已发表,供参考!

Reply to the comments on JBMR-A-05-0172

Comment:

Reference #10 is missing from the Introduction but used much later in the manuscript. Should these be in order used in manuscript?

Reply:

The missing reference has been added into the revised manuscript.

Comment (continued):

What is the sample size for all tests performed?

Reply:

The sample size for drug release and PCL degradation tests was 3.0×3.0 cm2, with a thickness of about0.1mmand a weight of about 40mg. This dada have been added into the revised manuscript.

Comment (continued):

Figure 7. There is no SCIentific evidence presented in the TEM figure to convince this reviewer of sub-jets. This statement on Page 9 cannot be made without clear evidence during the jet formation/separation. Figure 7 is just a large fiber and small fiber fused together, no other conclusion than this can be made.

Reply:

Necessary change in the statements has been made in the revised manuscript. as well as in the referred figure accordingly.

Comment (continued):

Table 3: Need standard deviation for all values reported not just for a select few.Equation after Table 3 not necessary. Just reference method used.

Reply:

Done accordingly.

Comment (continued):

Page 11: "faster weight loss" What was the sample size? Where is the statistical analysis of this data? This reviewer does not see a significant difference in any of the data presented, thus weight loss would be considered equivalent.

Reply:

Although not too much difference was seen, the conclusion that "the GS/PCL membrane exhibited a relatively faster weight loss compared with the RT/PCL membrane' was indeed applicable through "one-way analysis of variance (ANOVA)' analysis. Following the reviewer's comment, a new sub-section has been added to the manuscript. to address the statistical analysis for the data.

Comment (continued):

Page 12: What is the sample size for release data? Looks like results based on a sample size of one? Need stand deviations on the data presented in Figure 11. Why wasn't release

performed and compared for all electrospun conditions investigated otherwise?

Reply:

Three repeated tests were performed for each set of measurements and the resulting data were averaged. As stated in the revised manuscript, each sample had a square area of 33cm2 with a slightly different thickness.Standard deviations have been added to the data shown in Fig. 11.The present manuscript. aimed to show that medical drugs can be encapsulated in ultrafine fibers through a co-axial electrospinning process. The drug release data intended to show that the encapsulation was successful. We did not consider any specific application in this preliminary paper, and in fact the two drugs were just chosen as model illustration. As such, there seemed not necessary to perform. release experiments for all of the membranes electrospun with different conditions (i.e. the core concentrations)

Comment (continued):

Table 3: Yang's or Young's Modulus (page 10 says Young's).

Reply:

Corrected accordingly.

Comment (continued):

Figure 11: What is the % release, not just concentration. Why just this small sample of release data? Where is the release data for the other conditions?

Reply:

Unfortunately, we did not measure the amount of the shell material in obtaining the composite nanofibers. Namely, the flow rate of the shell solution during the electrospinning was not accurately controlled using an injecting pump. Hence the % release was not applicable. Please refer to the previous reply related to Page 12 and Figure 11 for the remaining comments.We acknowledge the reviewer's comments and suggestions very much, which are valuable in improving the quality of our manuscript.

附3:sci生物医学英语文章发表成功经验发表成功经验 

sci生物医学英语文章发表成功经验共享系列一---(Clinical Chemistry)

将自己近10年的科研工作中有关文章整理总结发表方面的一些信息贡献出来,与大家共享!如有时间,我拟将一些已经发表的论文,按照撰写与发表的实际经历与过程,即通过案例分析每一个杂志的特色,审稿偏好,review建议及答复要点等逐一分析.可能包含的杂志系列有:nature methods,clinical chemistry,analytical chemistry,J. Clin. Immuno,Biomed. Microdev,Front. BioSCI,Mol. Cell. Biochem,J. Expert,Rev. Proteomics,J biochemistry等.

本章先讲解美国Clinical Chemistry杂志,一个临床化学界的王牌杂志,近年其影响因子逐年攀升,现为分.Clinical Chemistry由美国AACC每月出版,接受的论文包括与人体疾病相关的实验室研究,分析与分子诊断,仪器,资料处理,数据分析,临床研究等投稿.ISSN:0009-9147网络版ISSN:1530-8561

{URL}

{镜像URL}

{出版者}American Association for Clinical Chemistry (AACC)

{收费情况} 免费,全文

{内容简介}

Clinical Chemistry is an international journal of laboratory medicine and molecular diagnostics.Clinical Chemistry -- This highly respected and often-cited SCIentific journal is published monthly and contains peer-reviewed methodology, research papers and other articles relevant to clinical chemistry and related laboratory SCIences. Its circulation is more than 15,000.David E. Bruns, MD, Editor, (Charlottesville Office)

dbruns@clinchem.aacc.org

Sandra Weaver, Senior Editorial Assistant

sweaver@clinchem.aacc.org

Donna Brandl, Editorial Assistant

dbrandl@clinchem.aacc.org

Shane P. Cyr, Editorial Assistant

scyr@clinchem.aacc.org

Mac Fancher, Publisher, (WashingtonOffice)

mfancher@aacc.org

Miriam Gonzalez, Publications Coordinator

mgonzalez@aacc.org

{目录/摘要或全文上网等情况}

Free TOC, 1965 -

Free Abstract, 1975 -

Free Fulltext, 1997 -1999

Fulltext, 1997 -

{杂志被索引的情况}

Indexed in Chemical Abstracts.

{备注}

For faster access to Clinical Chemistry Online from these countries use this URL:

, Brazil, China, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, Mexico,Russia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, The Netherlands, UK该杂志是由美国临床化学协会(American Association for Clinical Chemistry,AACC)主办的,于1948年成立,总部位于华盛顿,拥有1万余会员.先在网站注册,登记,按照提示一步步提供论文名称,摘要,作者姓名,所属领域,关键词,主文,图表等等.转换为PDF后就可以提交,然后给您一个查询号,接着就是等待了...

等了20多天,查阅状态看到了第一次回信:

Home Author Area Reviewer Area Personal Info. ClinChem Home Sign Out Submit New Manuscript. Information for Authors Queue Summary Feedback Help FAQ

Decision Letter

[Return to Queue]

To:作者姓名(电子邮件)

From: clinchemed@clinchem.aacc.org

Subject: Clinical Chemistry -- Manuscript. Decision

Cc:

RE: Clinical Chemistry MS ID# CLINCHEM/2002/036332

TITLE:

Dear Dr. xxx:

Your manuscript. has been examined by two expert reviewers. Please visit to view their comments. For the reasons detailed in these comments, we cannot accept this manuscript. for publication in Clinical Chemistry in this form. Also, your Reference 28 is not formatted properly. Our Information for Authors will offer assistance with journal style; it can be found at, be sure to provide a detailed point-by-point response to the comments of the reviewers. Failure to do so will delay consideration of the revised manuscript.Prior to publication we require copyright releases signed by all authors. Our Authors Assurances and Assignment of Copyright form. can be downloaded from (a signature on the lower section means that all conflicts of interest have been disclosed even if there are none). Send the completed form. to us by FAX (434-979-7599).

Sincerely,

Dr. xxx nesley

Associate Editor

P.S. You will find your revised manuscript. can be uploaded in your "Submit a Revision" queue at . Please do not begin the submission of your revised manuscript. until you are ready to submit the entire manuscript. A checklist regarding requirements for submission can be found at, you may use PowerPoint software for figures but fonts must be embedded and only one image per slide, one slide per file. When uploading the revised version, please be sure to include in the "Response to Reviews" field a point-by-point list of all changes made, or your rebuttal, in response to each of the reviewers?

suggestions.

P.P.S. Please note that if your manuscript. has color figures, the authors are expected to bear the cost of printing them, except in the case of invited papers. The charges for these figures are $1500 for the first color figure or part of a figure, and $500 for each additional color figure or part of a figure. Authors will be billed for color publication costs unless they request that their figures be printed in black and white.

该杂志一般为2个审稿人,审稿过程也较严格,都是本领域的大牛.后来我还有幸在一次会议上认识到一个当年的审稿人,但不知道是1还是2,呵呵!一般总是先鼓励一段话,不写了...

下面问题就来了,共12个,有些很好回答,一句话就可以解释清楚,有些就比较麻烦.还是举例说明把

--------------------------------------------------------------------------------------

1)实验的有效性和深度(at least for a few substances of major importance

detection limits, cut-off values and specificity should have been

studied. Also the description of the assay principle is not quite

clear)

没办法,只有一条路,补充相关实验,然后再投.

2)语言问题(The English text would have to be substantially improved)

虽然这是一个美国杂志,但对语言的要求一点都不弱,投之前还是忽略了,没办法,慢慢修改.

3)核心的技术问题(A cut-off value is given for MOL but the dimension is missing. In the discussion various anecdotic reports are given for which no data are presented under results.) 重新验证讨论. 本来认为很快就可以接受了,没想到却又等了一个半月(中间发过一次信件询问)才收到回信.原来除了上次2个评委,这次又增加了一个独立审稿人...

原文如下:

Your revised manuscript. has been examined by the original two reviewers, plus a recommended third reviewer with special expertise in this area. Please visit to retrieve their comments. The three reviewers find merit in the work, but have numerous constructive suggestions(别害怕,其实就是几个小问题). Please consider these suggestions carefully and prepare an improved version that addresses these concerns. I have also noted that there are several color figures included in the paper, which seem to be useful only in color. Please be aware that (should your paper be accepted for publication) authors are expected to pay the costs for publication of color figures. The charge for the first color figure is $1500; subsequent figures, or parts of figures, are $500 each. Of course, if you wish to submit alternate figures in black and white (or grayscale), you may do so.

Sincerely,

Dr. xxx

Associate Editor

P.S. You will find your revised manuscript. can be uploaded in your "Submit a Revision" queue at . A checklist of requirements for submission can be found at , please be sure to include in the "Response to Reviews" field a point-by-point list of all changes made, or your rebuttal, in response to each of the reviewer suggestions. Also, please submit copyright releases for all authors. Our Authors' Assurances and Assignment of Copyright form. can be downloaded from (434-979-7599).P.P.S. For figures, please submit .tif files that have a minimum resolution of 600 DPI; the width and height of the Pixels should be about 4200 x 4200. Alternatively, you may use PowerPoint for figures, but each .ppt file may contain only one slide and fonts must be embedded.

总之一句话,还是需要再次修改.

又等了接近1个月时间,幸亏不是学生赶毕业,最终被接收了.

Thank you for your revised manuscript. It is acceptable and will be processed for publication. Please note that I edited the paper to remove all text related to Figure 6. The structures of the drugs are available to anyone who wants to look them up. Thus this figure will not be in the proofs that you receive.

如果proof快的话,这个杂志一般会安排在2-3个月后发表.

If page proofs are returned promptly, your paper is scheduled to appear in the Oct issue.之前电子版会先在网上发布Papers in press are posted online 2-6 weeks before the issue date. Issues are scheduled to be mailed to subscribers and appear on the Internet before the first day of the issue month. The electronic version () is published at Stanford University's HighWire Press, where your article will be linked electronically to and from PubMed and directly to and from over 340 other journals that are on-line at Stanford.当然还要转移版权Prior to publication we require copyright releases signed by all authors. Our Authors Assurances and Assignment of Copyright form. can be downloaded from (a signature on the lower section means that all conflicts of interest have been disclosed even if there are none).

Thank you for this contribution.

Sincerely,

Dr. xx

Associate Editor

 

 

更多科研论文服务,动动手指,请戳 论文润色投稿期刊推荐论文翻译润色论文指导及修改、论文预审

语言不过关被拒?美国EditSprings--专业英语论文润色翻译修改服务专家帮您!

上一篇:【严正申明】关于我公司网站被恶意抄袭严正声明

下一篇:SCI论文的三种拒稿形式,形式,SCI,EditSprings,艾德思

特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。

凡注明来源为“EditSprings”的论文,如需转载,请注明来源EditSprings并附上论文链接。

最热论文